Clinical TrialsSearch results
Number of results: 604
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Z-206 Phase III Clinical Trial
-Investigation on the remission–maintaining effect in patients with Crohn's disease in remission phase-
- Patients with Crohn's disease in remission phase
- Zeria Pharmaceutical Co.,LTD.
- 2005-12-22
Other
- Z-206 Phase III Clinical Trial
- Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phase -
- Patients with ulcerative colitis in remission phase.
- Zeria Pharmaceutical Co.,LTD.
- 2005-11-21
Other
- Z-206 Phase III Clinical Trial
- Investigation on the remission-inducing effect in patients with ulcerative colitis in active phase -
- Patients with ulcerative colitis in active phase
- Zeria Pharmaceutical Co.,LTD.
- 2005-11-21
Other
- Z-206 Phase III Clinical Trial
- Investigation on the remission-inducing effect in patients with Crohn's disease in active phase -
- Patients with Crohn's disease in active phase
- Zeria Pharmaceutical Co.,LTD
- 2005-12-22
Other
- Visceral Fat Accumulation and Coronary Artery Disease Investigation in Japan
- subjects in Ningen Dock, people who recieve routine medical checkups, and coronary artery disease patients
- Osaka University
- 2010-03-31
Recruiting
- vedolizumab-4026
- Subjects with UC
- Fujiya Mikihiro
- 2020-11-06
Other
- Validity of Urine trypsinogen-2 in Diagnosis of Acute Pancreatitis -Multi-Center Study -
- The patient with abdominal pain that may have acute pancreatitis
- Japanese Society for Abdominal Emergency Medicine
- 2009-01-29
Other
- Validation study VI of febrile neutropenia guideline 2004
- Febrile Neutropenia
- Japan Febrile Neutropenia Study Group
- 2006-08-04
Other
- Validation study of new febrile neutropenia guideline-Comparative study between oral levofloxacin and parenteral cefepime in low-risk patients with febrile neutropenia
- Febrile neutropenia
- Japan Febrile Neutropenia Study Group
- 2006-04-04
Recruiting
- Vaccination trial with the PBF-derived peptide in HLA-A24+ patients with osteosarcoma
- Osteosarcoma
- Dept Orthopaedic Surgery, Sapporo Medical University
- 2009-01-14